Literature DB >> 22814093

Delusions increase functional impairment in Alzheimer's disease.

Corinne E Fischer1, Zahinoor Ismail, Tom A Schweizer.   

Abstract

BACKGROUND/AIMS: Delusions in Alzheimer's disease (AD) may be associated with functional impairment. No studies to date have used functional instruments sensitive to changes in frontal executive function, possibly underestimating the impact.
METHODS: Patients with AD with and without delusions were administered cognitive tests and questionnaires to assess depression and quality of life. Caregivers were administered questionnaires to assess functional impairment, caregiver burden and behavioural symptoms.
RESULTS: AD patients with delusions (n = 19) when compared to AD patients without delusions (n = 19) matched for age, education and global cognitive function were significantly more functionally impaired based on performance on the Disability Assessment for Dementia Scale (p < 0.005).
CONCLUSION: AD patients with delusions have significantly worse functional performance.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22814093     DOI: 10.1159/000339954

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  20 in total

1.  Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.

Authors:  Corinne E Fischer; Winnie Qian; Tom A Schweizer; Colleen P Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; Paul Shelton; David G Munoz
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

2.  Gray Matter Changes Associated With the Development of Delusions in Alzheimer Disease.

Authors:  Winnie Qian; Tom A Schweizer; Nathan W Churchill; Colleen Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; David G Munoz; Joseph J Barfett; Tarek K Rajji; Corinne E Fischer
Journal:  Am J Geriatr Psychiatry       Date:  2018-10-02       Impact factor: 4.105

3.  Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.

Authors:  Julia Kim; Corinne E Fischer; Tom A Schweizer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

4.  Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.

Authors:  Zahinoor Ismail; Eric E Smith; Yonas Geda; David Sultzer; Henry Brodaty; Gwenn Smith; Luis Agüera-Ortiz; Rob Sweet; David Miller; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2015-06-18       Impact factor: 21.566

5.  Gray matter atrophy in patients with mild cognitive impairment/Alzheimer's disease over the course of developing delusions.

Authors:  Corinne E Fischer; Windsor Kwan-Chun Ting; Colleen P Millikin; Zahinoor Ismail; Tom A Schweizer
Journal:  Int J Geriatr Psychiatry       Date:  2015-03-27       Impact factor: 3.485

Review 6.  Neuropsychiatric Symptoms in Mild Cognitive Impairment.

Authors:  Damien Gallagher; Corinne E Fischer; Andrea Iaboni
Journal:  Can J Psychiatry       Date:  2017-03       Impact factor: 4.356

7.  The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.

Authors:  Zahinoor Ismail; Luis Agüera-Ortiz; Henry Brodaty; Alicja Cieslak; Jeffrey Cummings; Corinne E Fischer; Serge Gauthier; Yonas E Geda; Nathan Herrmann; Jamila Kanji; Krista L Lanctôt; David S Miller; Moyra E Mortby; Chiadi U Onyike; Paul B Rosenberg; Eric E Smith; Gwenn S Smith; David L Sultzer; Constantine Lyketsos
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Accelerated atrophy in dopaminergic targets and medial temporo-parietal regions precedes the onset of delusions in patients with Alzheimer's disease.

Authors:  Riccardo Manca; Jose Manuel Valera-Bermejo; Annalena Venneri
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-05-13       Impact factor: 5.270

Review 9.  Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.

Authors:  Zahinoor Ismail; Byron Creese; Dag Aarsland; Helen C Kales; Constantine G Lyketsos; Robert A Sweet; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2022-01-04       Impact factor: 44.711

10.  The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.

Authors:  Julia Kim; Tom A Schweizer; Corinne E Fischer; David G Munoz
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.